EDIT vs BEAM
EDIT and BEAM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | EDITEDITAS MEDICINE, INC. | BEAMBeam Therapeutics Inc. |
|---|---|---|
| Market cap | $406.99M | $2.75B |
| P/B | — | 2.57 |
| P/S | 10.0x | 19.7x |
| Revenue | — | $156.03M(TTM) |
| Revenue growth (YoY) | 25.4% | 120.0% |
| Net income | — | -$86.52M(TTM) |
| Earnings growth (YoY) | 32.5% | 78.8% |
| EPS, diluted | — | $-0.69(TTM) |
| EBIT margin | -394.9% | -274.6% |
| ROE | -152.0% | -7.5% |
| ROIC | — | -40.5% |
| 1y total return | -14.0% | +6.3% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: EDIT frente a BEAM
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)